PRPrasob-Orn Rinthong

Prasob-Orn Rinthong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Prasob-Orn Rinthong has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Phenolic-Enriched Ethyl Acetate Fraction of Chatuphalatika Inhibits HMG-CoA Reductase and Preferentially Improves Hepatic Metabolic Parameters in High-Fat Diet-Fed Mice

    by Salin Mingmalairak, Prasob-Orn Rinthong

    Chatuphalatika is a traditional Thai polyherbal formulation whose metabolically active fraction has not been identified. This study fractionated the aqueous extract (CPT) by sequential liquid–liquid partitioning to obtain solvent fractions. The ethyl acetate fraction (CPTX) had the highest total phenolic content and was enriched in hydrolyzable tannins, particularly chebulagic acid. CPTX showed the strongest inhibitory activity against HMG-CoA reductase in vitro. In vivo, C57BL/6 mice were fed a high-fat diet for 12 weeks, then treated with CPT, CPTX, or silymarin for 8 weeks while high-fat diet feeding continued. Both CPT and CPTX improved serum lipid profiles. High-dose CPTX (500 mg/kg) additionally reduced fasting blood glucose, serum ALT, and relative liver weight, without affecting body weight or adipose tissue weights. These findings indicate that phenolic enrichment concentrates the hepatic and lipid-lowering activity of Chatuphalatika. HMG-CoA reductase inhibition was used as a screening criterion to identify CPTX as the active fraction; the in vivo hepatometabolic improvements are consistent with, but do not directly confirm, modulation of cholesterol biosynthesis and hepatic lipid metabolism.

  • Open Access

    Effects of Acanthus ebracteatus (Sea Holly) Aqueous Extract as a Functional Feed Additive on Growth Performance, Immune Responses, and Hepatopancreatic Histology in Pacific White Shrimp (Litopenaeus vannamei)

    by Wassana Prisingkorn, Pattama Wiriyapattanasub, Prasoborn Rinthong, Phadet Hongmanee, Sutee Wongmaneeprateep, Jariyavadee Suriyaphan, Apichet Pholoeng, Worapat Horjarlearn, Kanjana Thumanu, Kanokwan Kamkajon, et al.

    Intensive shrimp aquaculture has led to increased disease outbreaks and a greater reliance on antibiotics, driving the need for sustainable alternatives. This study examined the phytochemical profile, antioxidant activity, and effects of Acanthus ebracteatus (AC) aqueous extract as a natural feed additive on growth performance, and health in Pacific white shrimp (Litopenaeus vannamei). Phytochemical analysis of AC aqueous extracts revealed high concentrations of phenolics (162.1 ± 11.78 mg GAE/g), flavonoids (75.8 ± 2.32 mg RE/g), tannins (38.4 ± 0.78 mg TAE/g), and verbascoside (0.48 ± 0.01% w/w). Strong antioxidant capacity was confirmed with DPPH IC50 of 42.6 ± 11.78 µg/mL, ABTS IC50 of 2.93 ± 0.02 mg/mL, and FRAP value of 1.41 ± 0.08 mmol FeSO4/g extract. A feeding trial was conducted over eight weeks using 300 shrimp randomly assigned to four treatments: control diet and diets supplemented with 1%, 2%, and 3% AC aqueous extract. AC 2% supplementation showed optimal results for growth performance, including improved final body weight, weight gain, and feed conversion ratio. AC 3% treatment maximally enhanced immune responses, significantly elevating catalase, lysozyme, total antioxidant capacity, and hemocyanin, and glutathione peroxidase activity showed a numerical increase in AC-supplemented groups, particularly at the 3% inclusion level, although the differences were not statistically significant. AC 2% supplementation also improved hepatopancreatic histology through oxidative stress modulation and enhanced lipid metabolism. This study provides a comprehensive evaluation of AC aqueous extract by integrating phytochemical characterization, antioxidant profiling, and in vivo assessment of growth, immune response, and hepatopancreatic morphology in Pacific white shrimp.


  • Lipid-lowering and weight-regulating effects of Triphala aqueous extract in a therapeutic rat model of hypercholesterolemia

    by Wanlaya Naowaratwattana, Ladachart Taepongsorat, Bunleu Sungthong, Prasob-Orn Rinthong

    Introduction: Triphala, an Ayurvedic polyherbal formulation composed of Terminalia chebula Retz., Terminalia bellirica (Gaertn.) Roxb., and Phyllanthus emblica L., is associated with metabolic regulation. This study evaluated the lipid-lowering effects of Triphala aqueous extract (TPL) in a therapeutic rat model of hypercholesterolemia and explored a potential mechanism involving 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibition. Methods: Male Wistar rats received cholesterol (2 g/kg, intragastric) in corn oil for 3 weeks to induce hypercholesterolemia. After biochemical confirmation, rats were assigned to six groups (n = 6 each): normal diet, hypercholesterolemic control, atorvastatin (10 mg/kg), or TPL (250, 500, and 1000 mg/kg). Cholesterol administration continued throughout the 6-week treatment period. Serum lipid profiles and body weight were monitored. HMG-CoA reductase inhibition by TPL and individual fruit extracts was assessed. Results: TPL 250 and 500 mg/kg significantly reduced total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C), whereas TPL 500 mg/kg significantly increased high-density lipoprotein cholesterol (P<0.05). TPL 1000 mg/kg produced lipid-lowering effects comparable to atorvastatin and significantly decreased the atherogenic index of plasma at week 6. In vitro, TPL inhibited HMG-CoA reductase by 36.4±1.5% (5 µg/mL), compared with 82.5 ± 2.4% for pravastatin (0.5 µg/mL). Among individual fruit extracts, P. emblica exhibited the strongest inhibitory activity, followed by T. chebula and T. bellirica, while the combined TPL retained appreciable activity. TPL 1000 mg/kg also attenuated diet-induced body weight gain. Conclusion: TPL exerts significant lipid-lowering and weight-regulating effects under sustained cholesterol challenge, partly mediated by HMG-CoA reductase inhibition, supporting its potential as a natural adjunct for dyslipidemia.


  • Open Access

    Curcumin’s effects on growth indices, histological scores, blood metabolites, redox state, immunity, and antioxidant-related genes of red tilapia (Oreochromis sp.)

    by El-Sayed Hemdan Eissa, Ohaad F. Awlya, Wafaa F. Abusudah, Alaa H. Qadhi, Yasmin M. Abd El-Aziz, Prasob-Orn Rinthong, Sameh A. Abdelnour, Mohammad Bodrul Munir, Moaheda E. H. Eissa, Salah El-Sayed Sakr

    Curcumin, a polyphenol, targets multiple signaling molecules and shows activity at the cellular level, supporting its various health benefits. Thereafter, the present study examines the effects of different doses of dietary curcumin on growth indices, feed efficiency, serum metabolites, redox (oxidation) status, immunity, histological assessment, and antioxidant-related genes in red tilapia (Oreochromis sp, Oreochromis aureus x O. mossambicus). A total of 1200 red tilapia with an average weight of 19.1±0.03 g were distributed in 12 cement ponds (3×3.5×1m). Each treatment was assigned three pounds (n=100 replicates). For 60 days, fish were fed baseline diets containing 0, 0.4, 0.6, and 0.8 g of curcumin/kg of diet. The treated fish showed increased body weight and SGR (specific growth rate) compared to the T0 group (PP < 0.05). Curcumin supplementation showed no influence on feed intake, fish mortality, or survival rate (P >0.05). The curcumin-treated fish groups improved tissue structure in hepatocytes, pancreatic lumens, hepatic blood sinusoids, and intestine tissue layers, particularly the mucosal layer. The T0.8 group had reduced liver enzymes (AST and ALT) and greater total protein and albumin levels (PP < 0.05). Curcumin groups demonstrated significantly higher antioxidant indices (CAT, GPx, and SOD) compared to the basal diet (PPPOreochromis sp.) diets may improve the fish’s growth, health, tissue composition, and antioxidant response.


  • Open Access

    Molecular docking studies of Triphala with catalytic portion of HMG-CoA reductase enzyme

    by Prasoborn Rinthong, Pawitra Pulbutr, Chawannuch Mudjupa

    Introduction: Triphala, consisting of three fruits, Phyllanthus emblica L. (Phyllanthaceae), Terminalia bellirica (Gaertn.) Roxb. (Combretaceae), and T. chebula Retz, is a well-recognized Ayurvedic herbal formulation, used for various therapeutic purposes, including the treatment of dyslipidemia. Inhibitory activity against 3‑hydroxy‑3‑methylglutaryl‑coenzyme A (HMG‑CoA) reductase, a rate-limiting enzyme in the endogenous cholesterol synthesis pathway, is an essential target for the management of hypercholesterolemia. This in silico study aimed to investigate the HMG-CoA reductase inhibitory activity of the phytochemical compounds derived from Triphala formulation by employing molecular docking analysis. Methods: Ten phytochemical constituents of Triphala formulation were selectively used for docking study by using the HMG-CoA reductase template (PDB: 1HWK). Docking analysis was performed using AutoDock 4.2. The candidates were ranked by the binding energy parameters. Results: From the docking studies, the phytochemical compounds with HMG-CoA reductase inhibition could be classified into 4 groups, including phytosterols, polyphenols, tannins, and flavonoids. Beta-sitosterol exhibited the highest binding affinity to HMG-CoA reductase with a binding energy of -7.75 kcal/mol. Conclusion: These 10 phytochemical compounds in Triphala potentially exert their cholesterol-lowering effects via inhibition against HMG-CoA reductase. Nonetheless, further in vitro and in vivo experiments should be conducted subsequently to confirm this finding.


  • The effects of Terminalia chebula, Terminalia belerica, Phyllanthus emblica and Triphala on the growth performance and immune response in Nile tilapia ( Oreochromis niloticus )

    by Wassana Prisingkorn, Prasob‐Orn Rinthong, Bundit Yuangsoi, Sompong Doolgindachbaporn, Pattama Wiriyapattanasub, Hien Van Doan, Hui Gong Jiang, Sutee Wongmaneeprateep

    The supplementation of functional feed in aquafeed can enhance immunity, growth performance and survival rate of fish. Triphala is one of the most popular herbal formulations in traditional Ayurvedic medicine. It is rich in gallic, chebulagic and chebulinic acids. Triphala is composed of equal ratios of Terminalia chebula, Terminalia belerica and Phyllanthus emblica. The present study aimed to investigate the effect of each of the three herbal compounds of triphala, as well as triphala itself, on the growth, immunity and plasma biochemistry of Nile tilapia (Oreochromis niloticus). We conducted a 60-day growth trial on Nile tilapia using five different dietary groups: control, Terminalia chebula, Terminalia bellirica, Phyllanthus emblica and triphala. The results showed a negative effect of Terminalia chebula on growth of tilapia, whereas Terminalia chebula and Terminalia bellirica caused signs of abnormal liver health (swollen hepatocytes and absent nuclei), so these two plants appear to have negative effects on fish health when used individually, whereas Phyllanthus emblica and triphala improved growth performance and health of Nile tilapia. Triphala had a positive impact on several plasma biochemical parameters: reduced tChol, triglycerides, LDL, ALT and AST. These results suggest that triphala can improve fish health and boost immunity, without any notable negative side effects, and as such has the potential to be used as a functional feed additive in fish diets. Our results do not support the use of the individual components. The exact mechanisms through which triphala compounds modulate the disease resistance, molecular effects and metabolic responses remain unknown and require further investigations.


  • Open Access

    Chatuphalatika, a Thai herbal formula, ameliorate obesity and dyslipidemia in high-fat diet fed mice

    by Salin Mingmalairak, Mayuree H Tantisira, Prasoborn Rinthong

    Background Chatuphalatika is a Thai traditional health tonic composing of four different herbs namely Terminalia bellerica Linn., T. chebula Retz., T. arjuna Roxb. and Phyllanthus emblica Linn. The fact that phytoconstituents of Terminalia species have been reported to ameliorate obesity and symptoms of metabolic syndrome prompt us to investigate acute toxicity as well as a lipid lowering activity of orally given chatuphalatika aqueous extract (CPT) in animal models. Methods CPT was prepared by decoction method and the phytochemical contents were quantified by HPLC analysis. The acute oral toxicity study of CPT was performed in Wistar rats following the protocol of the Organisation for Economic Co-operation and Development (OECD) guidelines No. 420. The assessment of lipid-lowering effect of CPT was carried out in high-fat diet (HFD) fed C57BL/6 mice model. Results Gallic acid was the highest content (137.10 ± 5.42 mg/g) found in CPT followed by chebulinic acid (73.60 ± 2.35 mg/g), chebulagic acid (62.60 ± 4.17 mg/g) and ellagic acid (5.2 ± 0.40 mg/g). No lethality and no signs of toxicity were observed in either male or female rats orally treated with CPT at a single dose of 2,000 and 5,000 mg/kg. Daily oral administration of 250, 500 or 1,000 mg/kg of CPT for 6 weeks to the HFD-induced dyslipidemia mice markedly reduced low density lipoprotein cholesterol (LDL-C) levels and increased high density lipoprotein cholesterol (HDL-C) levels, whereas the significant reduction of total cholesterol (TC) levels was observed only in the high doses of 500 and 1,000 mg/kg of CPT. Moreover, dyslipidemia mice received 1,000 mg/kg CPT exclusively showed the decrease in body weight gain. Conclusions The CPT was safe and effective for relieving dyslipidemia and reducing weight gain in animal model supporting further development as functional food for dyslipidemia or overweight population.